Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
about
Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease18F-FDG PET during stereotactic body radiotherapy for stage I lung tumours cannot predict outcome: a pilot studyPharmacokinetic Analysis of Dynamic 18F-Fluoromisonidazole PET Data in Non-Small Cell Lung Cancer.Pharmacokinetic analysis of hypoxia (18)F-fluoromisonidazole dynamic PET in head and neck cancer.Non-local means denoising of dynamic PET images.Patient-Specific Method of Generating Parametric Maps of Patlak K(i) without Blood Sampling or Metabolite Correction: A Feasibility Study.Generalized whole-body Patlak parametric imaging for enhanced quantification in clinical PETDual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions.Theoretical Analysis of Penalized Maximum-Likelihood Patlak Parametric Image Reconstruction in Dynamic PET for Lesion Detection.Molecular imaging for personalized cancer care.When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?Whole-body direct 4D parametric PET imaging employing nested generalized Patlak expectation-maximization reconstruction.Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity.Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region.Clinical significance of primary lesion FDG uptake for choice between oesophagectomy and endoscopic submucosal dissection for resectable oesophageal squamous cell carcinomas.
P2860
Q28359854-D1E75455-2EC5-44AF-932D-28CE5A85B8E8Q30474874-AE4D0EB2-1FEF-4A67-AE69-96E1873DAB6CQ31165401-777220C2-005D-4BF4-B604-A8BE30D61757Q33688715-58A290C2-64F9-406A-8C44-574A3611BA31Q35067483-F8BCF958-38F4-4CEF-9397-B622B9EEBD91Q35201670-BEE0C2BA-9CBC-486F-861A-BBD70BCE97FBQ36454757-01E0E464-87F8-445A-B7EE-030C717ED083Q36618941-A813F7F4-4EAC-4EB0-ACD1-20FF9A317ACBQ37201183-24E78756-D38F-40F8-9EA3-A6625A158AC3Q37999206-A0A8235D-2C51-4CBD-838A-7E4F4288BFC1Q38077707-E4153919-7749-4F0D-948C-88C30A3CF4BBQ39627244-46169EED-2BFC-4658-A044-378A5E306132Q46837736-437D4F56-A6DF-4D3B-A34A-31DA7F5789ECQ48299871-A831B7ED-F48D-49AD-A5A9-EC6405D76141Q53214090-C6867D3A-FF2F-4C52-9FE7-9F998F46E9C1
P2860
Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@en
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@nl
type
label
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@en
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@nl
prefLabel
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@en
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@nl
P2093
P356
P1433
P1476
Dynamic positron emission tomo ...... nant lung/mediastinal lesions.
@en
P2093
P304
P356
10.1378/CHEST.114.4.1105
P407
P577
1998-10-01T00:00:00Z